Guardant Health Pivotal Eclipse

Listing Websites about Guardant Health Pivotal Eclipse

Filter Type:

Guardant Health announces positive results from pivotal ECLIPSE …

(7 days ago) WEB- The test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90% - Results pave the way for first potential FDA-approved and …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/default.aspx

Category:  Cancer Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(9 days ago) WEBECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.businesswire.com/news/home/20221215006055/en/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer

Category:  Health Show Health

Guardant Health Reaches Target Enrollment of 12,750 Patients in …

(4 days ago) WEBTopline Data Release from ECLIPSE Planned for Mid-2022 Subject to Positive Study Outcome, Data Will Support a Premarket Approval (PMA) Submission to …

https://investors.guardanthealth.com/press-releases/press-releases/2021/Guardant-Health-Reaches-Target-Enrollment-of-12750-Patients-in-ECLIPSE-Pivotal-Study-for-its-LUNAR-2-Blood-Test-to-Detect-Colorectal-Cancer/default.aspx

Category:  Health Show Health

Guardant Health, Inc. - Guardant Health Initiates …

(1 days ago) WEBREDWOOD CITY, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood …

https://investors.guardanthealth.com/press-releases/press-releases/2019/Guardant-Health-Initiates-ECLIPSE-Pivotal-Study-for-its-LUNAR-2-Blood-Test-for-Colorectal-Cancer-Screening/default.aspx

Category:  Health Show Health

Guardant Health Announces ECLIPSE Study Update Call on May 9, …

(Just Now) WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report additional data from its pivotal ECLIPSE study at …

https://investors.guardanthealth.com/press-releases/press-releases/2023/Guardant-Health-Announces-ECLIPSE-Study-Update-Call-on-May-9-2023/default.aspx

Category:  Health Show Health

Guardant Health Initiates ECLIPSE Pivotal Study for its LUNAR-2 …

(2 days ago) WEBGuardant Health, Inc. has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood test to detect colorectal cancer (CRC) …

https://www.guardanthealthamea.com/guardant-health-initiates-eclipse-pivotal-study-for-its-lunar-2-blood-test-for-colorectal-cancer-screening/

Category:  Cancer Show Health

Guardant Health, Inc. - Guardant Health -ECLIPSE Study Results

(3 days ago) WEBGuardant Health -ECLIPSE Study Results. December 15, 2022. At Guardant Health Inc., we promise to treat your data with respect and will not share your …

https://investors.guardanthealth.com/events-and-presentations/presentations/presentation-details/2022/Guardant-Health--ECLIPSE-Study-Results/default.aspx

Category:  Health Show Health

Guardant Health, Inc. - Guardant Health announces new data to be

(9 days ago) WEBThe data from the pivotal ECLIPSE Study accepted as a late-breaking abstract highlights the performance of the Shield ™ blood test in detecting colorectal …

https://investors.guardanthealth.com/press-releases/press-releases/2023/Guardant-Health-announces-new-data-to-be-presented-at-2023-Digestive-Disease-Week-showcasing-the-potential-of-its-blood-based-technology-to-detect-colorectal-cancer/default.aspx

Category:  Health Show Health

Guardant Health Announces ECLIPSE Study Update Call on May 9, …

(7 days ago) WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report additional data from its pivotal ECLIPSE stud Guardant …

https://www.businesswire.com/news/home/20230504006138/en/

Category:  Health Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(7 days ago) WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today positive results from ECLIPSE (Evaluation of ctDNA …

https://www.marketscreener.com/quote/stock/GUARDANT-HEALTH-INC-46434671/news/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-th-42559249/

Category:  Health Show Health

Guardant Health presents additional information from ECLIPSE …

(2 days ago) WEBShi eld ™ blood test achieved overall 83% sensitivity and 90% specificity and demonstrated early-stage detection in range with other guideline-recommended non …

https://investors.guardanthealth.com/press-releases/press-releases/2023/Guardant-Health-presents-additional-information-from-ECLIPSE-study-at-2023-Digestive-Disease-Week-on-the-performance-of-Shield-blood-test/default.aspx

Category:  Health Show Health

Guardant Health Announces ECLIPSE Study Update Call on May 9, …

(5 days ago) WEBPALO ALTO, Calif., May 05, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report additional data from its …

https://finance.yahoo.com/news/guardant-health-announces-eclipse-study-120000559.html

Category:  Health Show Health

Guardant Health Reaches Target Enrollment of 12,750 Patients in …

(5 days ago) WEBGuardant Health Reaches Target Enrollment of 12,750 Patients in ECLIPSE Pivotal Study for its LUNAR ™-2 Blood Test to Detect Colorectal Cancer …

https://www.businesswire.com/news/home/20211217005118/en/Guardant-Health-Reaches-Target-Enrollment-of-12750-Patients-in-ECLIPSE-Pivotal-Study-for-its-LUNAR%E2%84%A2-2-Blood-Test-to-Detect-Colorectal-Cancer

Category:  Cancer Show Health

A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening

(1 days ago) WEBThe ECLIPSE (Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode) study was designed to evaluate the performance of the cfDNA blood-based test (Shield, Guardant Health) to

https://www.nejm.org/doi/full/10.1056/NEJMoa2304714

Category:  Health Show Health

Clinical Studies - GuardantHealth

(4 days ago) WEBThe ECLIPSE study is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of colorectal cancer compared to a …

https://guardanthealth.com/clinical-studies/

Category:  Cancer Show Health

Home - GuardantHealth

(2 days ago) WEBECLIPSE study results published. Guardant Health is hiring bright minds in diverse fields to solve some of the most profound challenges in human health today. Learn …

https://www-.guardanthealth.com/

Category:  Health Show Health

2022-12-15 NDAQ:GH Press Release Guardant Health Inc

(4 days ago) WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today positive results from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode), an over 20,000 patient registrational study evaluating the performance of its blood test for detecting colorectal cancer (CRC) …

https://stockhouse.com/news/press-releases/2022/12/15/guardant-health-announces-positive-results-from-pivotal-eclipse-study-evaluating

Category:  Cancer Show Health

When the solar eclipse will happen, and how you can see it in NJ

(4 days ago) WEBEven on a cloudy, or rainy, day. In our part of New Jersey — say, Paterson — the sun will be about 92% obscured by the moon's shadow, Swangin said. Even if the …

https://www.northjersey.com/story/news/2024/03/08/total-eclipse-2024-nj/72759713007/

Category:  Health Show Health

FDA Advisory Panel Review of Guardant Health’s Shield - BioSpace

(Just Now) WEBPALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and …

https://www.biospace.com/article/releases/fda-advisory-panel-review-of-guardant-health-s-shield-blood-test-to-screen-for-colorectal-cancer-to-be-held-on-may-23/

Category:  Health Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(Just Now) WEBThe test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90%

https://discover.guardanthealth.com/2022/12/15/guardant-health-announces-positive-results-from-pivotal-eclipse-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/

Category:  Cancer Show Health

April 8, 2024 Partial Solar Eclipse in Bergen, New Jersey, USA

(Just Now) WEBWhere the Eclipse Was Seen. Detailed eclipse path map. 3D globe map. Try our new interactive eclipse maps. Zoom in and search for accurate eclipse times and visualizations for any location. Cloud Coverage (Apr 8) In the past, this day was cloudy 61% of the time (since 2000). Solar Eclipses

https://www.timeanddate.com/eclipse/in/@5095594?iso=20240408

Category:  Health Show Health

Here's Where to Get Approved Glasses in NJ to Watch The Solar …

(4 days ago) WEBWarby Parker will offer the glasses while supplies last. Beware of any retailers selling fake glasses that look like they should be worn in a 3-D movie theater. The …

https://www.njfamily.com/heres-where-to-get-approved-glasses-in-nj-to-watch-the-solar-eclipse/

Category:  Health Show Health

Filter Type: